Cargando…
Exoribonuclease in nonstructural protein 14 (nsp14-ExoN)
In vitro studies suggest nsp14-ExoN inhibitors could help sensitize coronaviruses to RNA mutagen therapeutics including ribavirin.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149067/ http://dx.doi.org/10.1038/scibx.2013.998 |
Ejemplares similares
-
Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity
por: Lin, Sheng, et al.
Publicado: (2021) -
Characterization of the SARS-CoV-2 ExoN (nsp14(ExoN)–nsp10) complex: implications for its role in viral genome stability and inhibitor identification
por: Baddock, Hannah T, et al.
Publicado: (2022) -
Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN
por: Moeller, Nicholas H., et al.
Publicado: (2021) -
Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN
por: Moeller, Nicholas H., et al.
Publicado: (2022) -
Murine Hepatitis Virus Exoribonuclease nsp14 Is Required for the Biogenesis of Viral Circular RNAs
por: Yang, Shaomin, et al.
Publicado: (2023)